Avanos sess

Avanos Medical, Inc. We use a variety of technologies to learn more about how people use the Site.

All participants will be in listen-only mode. Please go ahead. Good morning, everyone, and thanks for joining us. Joe will review our fourth quarter and full year results, the current business environment, as well as provide an update on our transformation efforts. The presentation for today's call is available on the Investors section of our website, avanos. As a reminder, our comments today contain forward-looking statements related to the Company, our expected performance, current economic conditions and our industry No assurance can be given as to future financial results. Actual results could differ materially from those in the forward-looking statements.

Avanos sess

.

And as Joe just mentioned, the capital sales that does not include zero. Thomson Reuters StreetEvents.

.

We use the latest and greatest technology available to provide the best possible web experience. Please enable JavaScript in your browser settings to continue. Download Foursquare for your smart phone and start exploring the world around you! Foursquare City Guide. Log In Sign Up.

Avanos sess

Avanos offers a wide variety of innovative, high-quality enteral feeding tubes and accessories uniquely designed for delivering nutrition and medication to pediatric and adult patients. Helping your patients face the use of a feeding tube, possibly for a lifetime, can be a challenge. The Avanos line of tubes and accessories can help you make the right choice for your patient. Avanos enteral feeding products are designed with your patients' comfort and safety in mind. From our feeding tubes to our placement… Read More Your visit to this site and use of the information hereon is subject to the terms of our Legal Statement. Please Review our Privacy Statement. Please review your California Privacy Rights. Please Review our Cookies Policy.

35 douglas street clovelly

This performance gives us confidence in our ability to be within the range of the financial targets we established last year during our Investor Day. Operator, please open the line for questions. Good morning, everyone, and thank you for joining us to review our operational and financial results for the fourth quarter and full year These are early signs that our new go-to-market strategy and structure for this part of the portfolio supports our low single digit growth expectations for We've addressed most of our supply and quality issues, which has given confidence to our commercial team. And then on top of that, we've got working capital opportunities in inventory. Nasdaq FTSE 7. I appreciate what you said about your strategy and your discipline, but maybe talk to us a little more depth about you talked about some of the commercial team sales changes. We think it's a low single-digit grower once we make our way through this year.

The Enteral Access Dilation System empowers clinicians to reach the desired dilation without having to rely upon multiple tools. This comprehensive telescoping device has added advantages, such as the reduction of repeat passings over the guidewire. Moreover, the peel-away feature makes for easier tube placement.

You talked about it a bit as well as some of the programs you're implementing to stabilize that part of the business. As you can see, we've made substantial progress against our transformation priorities. Or is it just some mid-single digit that you're reiterating the mid-single digit Yes. That would be great. Net sales negatively impacted our margin profile. We still anticipate consistent mid-single digit organic growth for '24 and , albeit this growth rate will be off a lower base due to the decreased sales in our ag business that we have already discussed. Information generated to better understand how to improve the Site. Please see today's press release and the risk factors described in our filings with the SEC. See here for details of each type of cookie used on the Avanos website. On top of that, our operational cash flow will be improving and just by nature of the revenue going up mid-single digits and the margin improvement the cost management takeout. This is a strategic area for us because of the focus on orthopedic pain and recovery, and it fits nicely into into our channel has great gross margin. Finally, our newly acquired Trident product line has produced results in line with our expectations. We have successfully executed the product ex-US.